Tag: Matthew Levinstein
Ingenia eyes USD42m IPO as first US company listing in Korea
Ingenia Therapeutics’ KRW60 billion (USD42.4 million) IPO to become first listing of a US-based company in Korea
Ingenia Therapeutics’ KRW60 billion (USD42.4 million) IPO to become first listing of a US-based company in Korea
India’s 2026 model BIT must align investment protection with climate obligations for long-term treaty coherence